RN7SKP19

Across TCGA pan-cancer cohorts, RN7SKP19 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RN7SKP19 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SKP19 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP19 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

BLCA, STAD, and UCEC are the cancer types where RN7SKP19 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.051	0.720	<.001	144	view →
STAD	OS	Tertile	III,IV	0.259	0.649	<.001	126	view →
UCEC	OS	Tertile	II,III,IV	0.141	0.768	<.001	84	view →
LGG	DFS	Tertile	All	0.089	0.845	<.001	15	view →
SKCM	OS	Tertile	All	0.791	0.330	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RN7SKP19–BLCA (OS)

Open the BLCA breakdown →